Prosper

Prosper is a private investment firm based in Poland, focusing on investments in the medical, biotechnology, and pharmaceutical sectors. The firm was founded by Tadeusz Wesołowski, who has a background in technical sciences and extensive experience in the pharmaceutical industry. Prosper has been involved in various ventures, including the establishment and management of Prosper S.A., a leading pharmaceutical distribution company in Poland. In 2009, Prosper S.A. merged with Torfarm S.A., forming Neuca S.A., a major player in the pharmaceutical distribution market.

After the merger, Tadeusz Wesołowski transitioned into a role as an investor, seeking opportunities in the biotechnology sector and other new technologies. He has been involved in venture capital funds such as Inovo and Experior, focusing on early-stage investments in innovative companies. Wesołowski's investment strategy emphasizes minority stakes, with individual investments ranging from several hundred thousand to a maximum of 10 million PLN, and a typical investment horizon of several years.

Through these activities, Prosper continues to contribute to the growth and development of the medical, biotechnology, and pharmaceutical sectors in Poland, leveraging its founder's expertise and network to identify and support promising ventures in these industries.